# clm_BADB05CE1396

subject: Gilead Sciences (/record/gilead-sciences.md)  
predicate: quarterly_research_and_development  
value: 937,000,000 United States dollar  
valid_from: 2018-03-31  
valid_to: 2018-06-30  
published: 2018-05-09  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_E1F6AE4E3122  
last_updated: 2026-11-08  
cite: AsOf. "Gilead Sciences quarterly research and development: 937,000,000 United States dollar", as of 2018-03-31 (until 2018-06-30). Claim clm_BADB05CE1396, https://asof.is/claim/clm_BADB05CE1396, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209518000015/0000882095-18-000015-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2018, filed 2018-05-09  

## Sources

- https://www.sec.gov/Archives/edgar/data/882095/000088209518000015/0000882095-18-000015-index.htm (primary, SEC EDGAR 10-Q Q1 FY2018, published 2018-05-09)

## Supersedes

- [Gilead Sciences](/record/gilead-sciences.md) | quarterly_research_and_development | 789,000,000 United States dollar | valid 2017-09-30 to 2018-03-31 | conf 0.95 | superseded | superseded_by [clm_BADB05CE1396](/claim/clm_BADB05CE1396.md) | [clm_C314071CED94](/claim/clm_C314071CED94.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.